Stevanato Group S.p.A. (STVN)
NYSE: STVN
· Real-Time Price · USD
25.01
0.43 (1.75%)
At close: Oct 09, 2025, 10:54 AM
1.75% (1D)
| Bid | 24.89 |
| Market Cap | 6.83B |
| Revenue (ttm) | 1.15B |
| Net Income (ttm) | 134.56M |
| EPS (ttm) | 0.58 |
| PE Ratio (ttm) | 43.12 |
| Forward PE | 31.7 |
| Analyst | Hold |
| Dividends | $0.06 |
| Ask | 25.02 |
| Volume | 12,454 |
| Avg. Volume (20D) | 391,250 |
| Open | 24.47 |
| Previous Close | 24.58 |
| Day's Range | 24.47 - 25.05 |
| 52-Week Range | 17.12 - 28.00 |
| Beta | 0.57 |
| Ex-Dividend Date | Jun 5, 2025 |
About STVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol STVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for STVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsStevanato Group S.p.A. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-9.73%
Stevanato Group shares are trading lower following...
Unlock content with
Pro Subscription
5 months ago
+3.12%
Stevanato Group shares are trading higher after the company reported a year-over-year increase in Q1 sales results.
2 months ago · businesswire.com
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,...
